HealthCare Royalty Partners, a private equity firm that invests in drug royalties and other health care-related investments, has rounded up $1.02 billion for its third fund, according to a filing with the Securities and Exchange Commission.

from Dow Jones Private Equity Analyst Plus Alert http://ift.tt/1npc1HB
via IFTTT

Publicités